In vivo IOL power determination possible

Article

Approximate in vivo intraocular lens (IOL) power can be determined using Scheimpflug imaging and could be applied in cases of unexplained postoperative refractive error.

Approximate in vivo intraocular lens (IOL) power can be determined using Scheimpflug imaging and could be applied in cases of unexplained postoperative refractive error, according to the results of a study published in the June issue of the Journal of Cataract and Refractive Surgery.

Stephen Turner and colleagues from the King's College Hospital Ophthalmology Department, London, UK assessed the feasibility of determining IOL power by measurement of the central optic thickness using clinically available Scheimpflug imaging. A total of 67 eyes were assessed one month after phacoemulsification with in-the-bag implantation of AcrySof MA60AC IOLs (Alcon). The correlation between IOL thickness measurement and IOL power was calculated and the repeatability of central optic thickness measurement was determined by 10 successive scans of four patients.

The coefficient of variability was 1.4% and the measured lens thickness was highly correlated with lens power (r2=0.94, p<0.001). Over the measured range, 95% confidence intervals varied between ±0.83 D and ±0.92 D.

The authors concluded that central IOL thickness measurements with the Scheimpflug camera are repeatable and closely correlate with the known IOL power, making in vivo IOL power determination a feasible option, especially in cases of unexplained postoperative refractive error.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
© 2025 MJH Life Sciences

All rights reserved.